DFVEX | VMVAX | DFVEX / VMVAX | |
Total Expense Ratio | 0.24 | 0.07 | 343% |
Annual Report Gross Expense Ratio | 0.24 | 0.07 | 343% |
Fund Existence | 20 years | 14 years | - |
Gain YTD | 5.362 | 3.573 | 150% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.86B | 29.9B | 16% |
Annual Yield % from dividends | 1.26 | 2.26 | 56% |
Returns for 1 year | 14.06 | 12.14 | 116% |
Returns for 3 years | 41.24 | 28.52 | 145% |
Returns for 5 years | 89.38 | 77.08 | 116% |
Returns for 10 years | 77.39 | 88.11 | 88% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FINSX | 48.04 | 0.50 | +1.05% |
Fidelity Advisor New Insights I | |||
MASKX | 24.78 | 0.25 | +1.02% |
iShares Russell 2000 Small-Cap Idx Instl | |||
MOJAX | 15.61 | 0.12 | +0.77% |
Donoghue Forlines Momentum A | |||
BRSTX | 14.58 | 0.11 | +0.76% |
MFS Blended Research Small Cap Eq R3 | |||
MWOKX | 67.65 | 0.36 | +0.53% |
MFS Global Growth R6 |